-
Holland TL, Raad I, Boucher HW, Anderson DJ, et al.
Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious
Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical
Trial. JAMA 2018;320:1249-1258.
-
Thwaites GE, Scarborough M, Szubert A, Nsutebu E, et al.
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a
multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2017.
-
Tun HW, Johnston PB, DeAngelis LM, Atherton PJ, et al.
Phase I study of pomalidomide and dexamethasone for relapsed/refractory primary
CNS or vitreo-retinal lymphoma. Blood 2018.
-
Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, et al.
Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to
hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group,
double-blind, randomised controlled trial. Lancet 2018.
-
Schachter J, Ribas A, Long GV, Arance A, et al.
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival
results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006). Lancet 2017.
|